TY - JOUR
T1 - Consistent Indications and Good Outcomes Despite High Variability in Techniques for Two-Stage Revision Anterior Cruciate Ligament Reconstruction
T2 - A Systematic Review
AU - Gopinatth, Varun
AU - Casanova, Felipe J.
AU - Knapik, Derrick M.
AU - Mameri, Enzo S.
AU - Jackson, Garrett R.
AU - Khan, Zeeshan A.
AU - McCormick, Johnathon R.
AU - Yanke, Adam B.
AU - Cole, Brian J.
AU - Chahla, Jorge
N1 - Funding Information:
The authors report the following potential conflicts of interest or sources of funding: J.R.M. has received support for education from Medwest Associates. D.M.K. has received support for education from Smith & Nephew, Elite Orthopedics, and Medwest Associates; hospitality payments from Arthrex, Encore Medical, Stryker, and Smith & Nephew; honoraria from Encore Medical; and a grant from Arthrex. A.B.Y. has received faculty/speaking payments from Arthrex; consulting, honororia, and hospitality payment from Joint Restoration Foundation; consulting and hospitality from Aastrom Biosciences; education payments from MedWest Associates; consulting fees from Olympus America; and hospitality payments from Stryker and Smith and Nephew. B.J.C. has received consulting and faculty/speaking fees from Arthrex; consulting and faculty/speaking fees from Pacira Pharmaceuticals; consulting and honoraria from Vericel; consulting and hospitality payments from Geistlich Pharma North America; consulting fees from Ossio LTD, Acumed, Bioventus, Anika Therapeutics, Endo Pharmaceuticals, Flexion Therapeutics, Smith and Nephew, and Zimmer Biomet Holdings; hospitality payments from Stryker, Orgenogenesis, LifeNet Health, and GE Healthcare; faculty/speaking fees from Terumo BCT, Aesculap Biologics, and LifeNet Health; investment interest in Cartiva; and royality payments from DJO. J.C. has received consulting fees from Arthrex, CONMED Linvatec Corporation, Ossur, Smith & Nephew, Vericel, Stryker Corporation, and DePuy Synthes Products; support for education from Arthrex, Medwest Associates, and Smith & Nephew; speaking fees from Linvatec, Arthrex, and Smith & Nephew; hospitality payments from Medical Device Business Services, Medwest Associates, Smith & Nephew, Linvatec, and Stryker; and a grant from Arthrex. Full ICMJE author disclosure forms are available for this article online, as supplementary material .
Publisher Copyright:
© 2023
PY - 2023
Y1 - 2023
N2 - Purpose: To systematically review the current literature regarding the indications, techniques, and outcomes after 2-stage revision anterior cruciate ligament reconstruction (ACLR). Methods: A literature search was performed using SCOPUS, PubMed, Medline, and the Cochrane Central Register for Controlled Trials according to the 2020 Preferred Reporting Items for Systematic Reviews and Meta Analyses statement. Inclusion criteria was limited to Level I-IV human studies reporting on indications, surgical techniques, imaging, and/or clinical outcomes of 2-stage revision ACLR. Results: Thirteen studies with 355 patients treated with 2-stage revision ACLR were identified. The most commonly reported indications were tunnel malposition and tunnel widening, with knee instability being the most common symptomatic indication. Tunnel diameter threshold for 2-stage reconstruction ranged from 10 to 14 mm. The most common grafts used for primary ACLR were bone–patellar tendon–bone (BPTB) autograft, hamstring graft, and LARS (polyethylene terephthalate) synthetic graft. The time elapsed from primary ACLR to the first stage surgery ranged from 1.7 years to 9.7 years, whereas the time elapsed between the first and second stage ranged from 21 weeks to 13.6 months. Six different bone grafting options were reported, with the most common being iliac crest autograft, allograft bone dowels, and allograft bone chips. During definitive reconstruction, hamstring autograft and BPTB autograft were the most commonly used grafts. Studies reporting patient-reported outcome measures showed improvement from preoperative to postoperative levels in Lysholm, Tegner, and objective International Knee and Documentation Committee scores. Conclusions: Tunnel malpositioning and widening remain the most common indications for 2-stage revision ACLR. Bone grafting is commonly reported using iliac crest autograft and allograft bone chips and dowels, whereas hamstring autograft and BPTB autograft were the most used grafts during the second-stage definitive reconstruction. Studies showed improvements from preoperative to postoperative levels in commonly used patient reported outcomes measures. Level of Evidence: IV, systematic review.
AB - Purpose: To systematically review the current literature regarding the indications, techniques, and outcomes after 2-stage revision anterior cruciate ligament reconstruction (ACLR). Methods: A literature search was performed using SCOPUS, PubMed, Medline, and the Cochrane Central Register for Controlled Trials according to the 2020 Preferred Reporting Items for Systematic Reviews and Meta Analyses statement. Inclusion criteria was limited to Level I-IV human studies reporting on indications, surgical techniques, imaging, and/or clinical outcomes of 2-stage revision ACLR. Results: Thirteen studies with 355 patients treated with 2-stage revision ACLR were identified. The most commonly reported indications were tunnel malposition and tunnel widening, with knee instability being the most common symptomatic indication. Tunnel diameter threshold for 2-stage reconstruction ranged from 10 to 14 mm. The most common grafts used for primary ACLR were bone–patellar tendon–bone (BPTB) autograft, hamstring graft, and LARS (polyethylene terephthalate) synthetic graft. The time elapsed from primary ACLR to the first stage surgery ranged from 1.7 years to 9.7 years, whereas the time elapsed between the first and second stage ranged from 21 weeks to 13.6 months. Six different bone grafting options were reported, with the most common being iliac crest autograft, allograft bone dowels, and allograft bone chips. During definitive reconstruction, hamstring autograft and BPTB autograft were the most commonly used grafts. Studies reporting patient-reported outcome measures showed improvement from preoperative to postoperative levels in Lysholm, Tegner, and objective International Knee and Documentation Committee scores. Conclusions: Tunnel malpositioning and widening remain the most common indications for 2-stage revision ACLR. Bone grafting is commonly reported using iliac crest autograft and allograft bone chips and dowels, whereas hamstring autograft and BPTB autograft were the most used grafts during the second-stage definitive reconstruction. Studies showed improvements from preoperative to postoperative levels in commonly used patient reported outcomes measures. Level of Evidence: IV, systematic review.
UR - http://www.scopus.com/inward/record.url?scp=85151442796&partnerID=8YFLogxK
U2 - 10.1016/j.arthro.2023.02.009
DO - 10.1016/j.arthro.2023.02.009
M3 - Review article
C2 - 36863622
AN - SCOPUS:85151442796
SN - 0749-8063
JO - Arthroscopy - Journal of Arthroscopic and Related Surgery
JF - Arthroscopy - Journal of Arthroscopic and Related Surgery
ER -